Video from AACC: Lab Ordering Cloud software Mehdi Maghsoodnia, CEO of 1health, spoke to ScienceBoard.net's sister site LabPulse.com about the market needs for the firm’s Lab Ordering Cloud, as well as diagnostic industry trends.Read More
Studies uncover findings on antibody responses, immunity Findings from two studies add to a growing body of knowledge that is essential for guiding public health initiatives and might one day enable clinicians to assess individuals’ immunity to SARS-CoV-2, according to AACC.Read More
Research shows heart-damaging route of SARS-CoV-2 spike protein Researchers have demonstrated that the spike protein from the SARS-CoV-2 virus can lead to heart muscle injury through the inflammation process, according to preliminary research to be presented this week at the American Heart Association’s 2022 Basic Cardiovascular Sciences Scientific Sessions.Read More
LumiraDx to discuss microfluidic technology at AACC LumiraDx announced that it will host an industry workshop at AACC 2022 on Wednesday, describing the impact of its microfluidic technology on lateral-flow antigen tests and the role of these rapid immunoassays in the response to the COVID-19 pandemic.Read More
Lessons from Operation Warp Speed could benefit future drug discovery What lessons can the biotech industry learn from Operation Warp Speed? In an interview with ScienceBoard.net, Debrah Thompson, PhD, of HTG Molecular Diagnostics, discusses how the success of the COVID-19 vaccine rollout could benefit the drug discovery process going forward.Read More
Moderna, IVI join forces for vaccine research and development Biotech giant Moderna and the International Vaccine Institute (IVI), a nonprofit inter-governmental organization headquartered in Seoul, South Korea, have signed a memorandum of understanding to collaborate on research and development for messenger RNA vaccines.Read More
NIH study shows how immune response to COVID-19 damages the brain A National Institutes of Health (NIH) study, which examined brain changes in nine people who died suddenly after contracting COVID-19, found that antibodies are involved in the attack on cells lining the brain's blood vessels, leading to inflammation and damage.Read More